This was further corroborated in our cohort with patients undergoing GTR of tumor, low grade tumor pathology on histology, and absence of NF-1 mutation trending toward having an improved OS (Fig. 3b, c) [1, 4, 9]. This evidence concerns the gene NF1 and neoplasm.